(Q34163182)

31 July 2017

1 reference

title

Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care (English)

1 reference

aneurysmal subarachnoid hemorrhage

31 July 2017

main subject

1 reference

Treggiari-Venzi MM

1

1 reference

31 July 2017

Suter PM

series ordinal

2

1 reference

31 July 2017

Romand JA

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

48

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

249-61; discussion 261-2

1 reference

Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

The relationship of blood velocity as measured by transcranial doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Balloon angioplasty for the treatment of vasospasm: results of first 50 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Clinical and angiographic outcomes, with treatment data, for patients with cerebral aneurysms treated with Guglielmi detachable coils: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Causes of unfavorable outcome after early aneurysm operation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

A review of hemoglobin and the pathogenesis of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

In vivo animal models of cerebral vasospasm: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Endovascular therapy for aneurysmal vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Comparison of transcranial Doppler investigation of aneurysmal vasospasm with digital subtraction angiographic and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Regional cerebral blood flow and metabolism in reversible ischemia due to vasospasm. Determination by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Safety and efficacy of endovascular treatment of acutely ruptured aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Complications of Swan-Ganz catheterization for hemodynamic monitoring in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Coagulopathy with the use of hetastarch in the treatment of vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200102000-00001

10.1097/00006123-200102000-00001

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference